DISCOVER: How to Potentially Multiply Your Returns by Upto 5x...
Here is the latest financial fact sheet of Lupin. For more details, see the Lupin quarterly results and Lupin share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -1.6 |
No. of shares | m | 452.65 |
% ch week | % | 0.8 |
% ch 1-mth | % | -1.8 |
% ch 12-mth | % | 55.4 |
52 week H/L | Rs | 1,121.9/505.0 |
No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
---|
LUPIN EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,127 | 1,750 | 1,465 | 986 | 882 | |
Low | Rs | 1,294 | 1,384 | 727 | 720 | 505 | |
Sales per share (Unadj.) | Rs | 316.4 | 387.4 | 349.6 | 324.1 | 339.4 | |
Earnings per share (Unadj.) | Rs | 50.2 | 56.6 | 5.6 | 13.4 | -5.9 | |
Diluted earnings per share | Rs | 49.9 | 56.5 | 5.6 | 13.4 | -6.0 | |
Cash flow per share (Unadj.) | Rs | 61.0 | 76.8 | 29.6 | 32.1 | 15.5 | |
Dividends per share (Unadj.) | Rs | 7.50 | 7.50 | 5.00 | 5.00 | 6.00 | |
Adj. dividends per share | Rs | 7.47 | 7.48 | 4.99 | 5.00 | 6.00 | |
Dividend yield (eoy) | % | 0.4 | 0.5 | 0.5 | 0.6 | 0.9 | |
Book value per share (Unadj.) | Rs | 247.8 | 298.9 | 300.3 | 303.7 | 276.7 | |
Adj. book value per share | Rs | 246.6 | 298.2 | 299.9 | 303.6 | 277.0 | |
Shares outstanding (eoy) | m | 450.58 | 451.58 | 452.08 | 452.49 | 453.00 | |
Bonus/Rights/Conversions | - | ESOP | ESOP | ESOP | ESOP | ||
Price / Sales ratio | x | 5.4 | 4.0 | 3.1 | 2.6 | 2.0 | |
Avg P/E ratio | x | 34.1 | 27.7 | 197.2 | 63.6 | -116.6 | |
P/CF ratio (eoy) | x | 28.0 | 20.4 | 37.1 | 26.6 | 44.8 | |
Price / Book Value ratio | x | 6.9 | 5.2 | 3.6 | 2.8 | 2.5 | |
Dividend payout | % | 14.9 | 13.2 | 90.0 | 37.3 | -100.9 | |
Avg Mkt Cap | Rs m | 770,740 | 707,513 | 495,502 | 386,064 | 314,201 | |
No. of employees | `000 | 16.4 | 16.8 | 17.0 | 17.7 | 18.3 | |
Total wages/salary | Rs m | 21,416 | 28,495 | 28,647 | 27,702 | 29,868 | |
Avg. sales/employee | Rs Th | 8,718.5 | 10,418.3 | 9,273.6 | 8,292.6 | 8,400.6 | |
Avg. wages/employee | Rs Th | 1,309.8 | 1,697.0 | 1,681.0 | 1,566.5 | 1,632.0 | |
Avg. net profit/employee | Rs Th | 1,382.6 | 1,523.0 | 147.4 | 343.0 | -147.2 |
LUPIN INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 142,555 | 174,943 | 158,042 | 146,646 | 153,748 | |
Other income | Rs m | 1,852 | 1,065 | 1,504 | 3,330 | 4,838 | |
Total revenues | Rs m | 144,407 | 176,008 | 159,545 | 149,976 | 158,585 | |
Gross profit | Rs m | 36,854 | 44,931 | 31,475 | 26,552 | 24,849 | |
Depreciation | Rs m | 4,871 | 9,122 | 10,859 | 8,461 | 9,702 | |
Interest | Rs m | 595 | 1,525 | 2,044 | 3,025 | 3,630 | |
Profit before tax | Rs m | 33,239 | 35,349 | 20,076 | 18,397 | 16,355 | |
Minority Interest | Rs m | -88 | -72 | -71 | -89 | 4 | |
Prior Period Items | Rs m | 49 | 83 | 35 | 38 | 39 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | -14,644 | -3,400 | -7,521 | |
Tax | Rs m | 10,593 | 9,785 | 2,885 | 8,879 | 11,571 | |
Profit after tax | Rs m | 22,607 | 25,575 | 2,513 | 6,066 | -2,694 | |
Gross profit margin | % | 25.9 | 25.7 | 19.9 | 18.1 | 16.2 | |
Effective tax rate | % | 31.9 | 27.7 | 14.4 | 48.3 | 70.8 | |
Net profit margin | % | 15.9 | 14.6 | 1.6 | 4.1 | -1.8 |
LUPIN BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 98,874 | 119,529 | 122,095 | 138,536 | 154,132 | |
Current liabilities | Rs m | 50,612 | 61,206 | 50,956 | 61,299 | 92,252 | |
Net working cap to sales | % | 33.9 | 33.3 | 45.0 | 52.7 | 40.2 | |
Current ratio | x | 2.0 | 2.0 | 2.4 | 2.3 | 1.7 | |
Inventory Days | Days | 84 | 76 | 85 | 95 | 82 | |
Debtors Days | Days | 116 | 90 | 120 | 128 | 129 | |
Net fixed assets | Rs m | 114,194 | 131,660 | 129,876 | 127,516 | 89,082 | |
Share capital | Rs m | 901 | 903 | 904 | 905 | 906 | |
"Free" reserves | Rs m | 110,733 | 134,073 | 134,866 | 136,517 | 124,461 | |
Net worth | Rs m | 111,634 | 134,976 | 135,771 | 137,422 | 125,367 | |
Long term debt | Rs m | 53,739 | 56,478 | 64,245 | 66,417 | 17,933 | |
Total assets | Rs m | 226,249 | 266,073 | 263,054 | 279,494 | 249,839 | |
Interest coverage | x | 56.9 | 24.2 | 10.8 | 7.1 | 5.5 | |
Debt to equity ratio | x | 0.5 | 0.4 | 0.5 | 0.5 | 0.1 | |
Sales to assets ratio | x | 0.6 | 0.7 | 0.6 | 0.5 | 0.6 | |
Return on assets | % | 10.3 | 10.2 | 1.7 | 3.3 | 0.4 | |
Return on equity | % | 20.3 | 18.9 | 1.9 | 4.4 | -2.1 | |
Return on capital | % | 20.4 | 19.3 | 3.7 | 8.8 | 8.7 | |
Exports to sales | % | 47.2 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 7.2 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 67,244 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 10,199 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 71,405 | 81,885 | 53,141 | 59,414 | 51,450 | |
Fx outflow | Rs m | 17,807 | 21,506 | 19,335 | 22,282 | 19,470 | |
Net fx | Rs m | 53,598 | 60,378 | 33,807 | 37,132 | 31,980 |
LUPIN CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -3,824 | 41,135 | 17,512 | 16,660 | 14,688 | |
From Investments | Rs m | -69,617 | -25,274 | 4,699 | -32,825 | 11,070 | |
From Financial Activity | Rs m | 58,364 | 4,332 | -14,921 | 7,441 | -8,906 | |
Net Cashflow | Rs m | -15,077 | 20,193 | 7,290 | -8,724 | 16,853 |
Share Holding
|
Company Information
|
CHM: D. B. Gupta | COMP SEC: R. V. Satam | YEAR OF INC: 1983 | BSE CODE: 500257 | FV (Rs): 2 | DIV YIELD (%): 0.6 |
Read: LUPIN 2019-20 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: TTK HEALTHCARE STRIDES PHARMA SCIENCE NATCO PHARMA WYETH SANOFI INDIA
Compare LUPIN With: TTK HEALTHCARE STRIDES PHARMA SCIENCE NATCO PHARMA WYETH SANOFI INDIA
Compare LUPIN With: ACTAVIS (US) MYLAN (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed huge selling during closing hours on Friday and ended lower.
Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.
For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.
Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More